Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 234Neoplasms 207Carcinoma, Non-Small-Cell Lung 101Colorectal Neoplasms 99Prostatic Neoplasms 89Lung Neoplasms 77Multiple Myeloma 53Melanoma 51Pancreatic Neoplasms 50Head and Neck Neoplasms 49Neoplasm Metastasis 48Leukemia, Myeloid, Acute 44Carcinoma, Hepatocellular 43Ovarian Neoplasms 39Brain Neoplasms 39Squamous Cell Carcinoma of Head and Neck 37Recurrence 37Glioblastoma 33Uterine Cervical Neoplasms 32Glioma 30Sarcoma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Stomach Neoplasms 28Lymphoma, Non-Hodgkin 28Lymphoma 27Colonic Neoplasms 27Carcinoma, Renal Cell 26Lymphoma, Follicular 25Esophageal Neoplasms 24Rectal Neoplasms 23

Interventions

itacitinib 1INCB039110 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × B-cell Malignancies × 90 days × Clear all
NCT01905813 2026-05-11

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Incyte Corporation

Phase 1 Completed
121 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡